logo

Kymera Therapeutics Inc (KYMR) Stock: A Year of Declines and Increases

Examining a stock’s 52-week price history, encompassing its low and high prices, can reveal much about its existing condition and potential future trajectory. Kymera Therapeutics Inc’s current trading price is -51.25% away from its 52-week high, while its distance from the 52-week low is 33.56%. The stock’s price range over this period has fluctuated between $19.44 and $53.27. The company, operating within the financial sector, had a trading volume of approximately 0.47 million for the day, which was noticeably lower than the average daily share volume of 0.68 million over the last 3 months.

Kymera Therapeutics Inc’s market performance has been unstable in recent times. The company’s stock hit a 1-year high of $53.27 on 09/26/24 and a low of $19.44 for the same time frame on 04/09/25.

Exploring Financial Performance and Market Capitalization: A Comprehensive Analysis

Kymera Therapeutics Inc (KYMR) has experienced a quarterly decline of -35.54% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 1.69B and boasts a workforce of 188 employees.

Analyzing Trading Volume and Moving Average Trends

Based on Barchart.com data, the company’s moving average over the 100-day period was 36.72, with a change in price of -18.08. Similarly, Kymera Therapeutics Inc recorded 614,140 in trading volume during the last 100 days, posting a change of -41.04%.

Understanding Ticker ‘s Debt-to-Equity Ratio: An Analysis

The debt-to-equity (D/E) ratio serves as an important indicator of a company’s financial stability and market position. By dividing a company’s total liabilities by its shareholders’ equity, the D/E ratio reveals the degree to which a company relies on debt to finance assets compared to its shareholders’ equity. At the time of writing, the total D/E ratio for KYMR stands at 0.11. Similarly, the long-term debt-to-equity ratio is also 0.09.

KYMR Stock Stochastic Average

Today, Kymera Therapeutics Inc’s raw stochastic average for the past 50 days stands at 32.46%, indicating a decline from the raw stochastic average of the last 20 days, which was 41.24%. Moreover, the company’s Stochastic %K and %D values over the past 20 days were 38.16% and 36.78% respectively.

KYMR Stock Price Performance Analysis

The performance of the stock price over the year has been up and down, leaving investors with either an optimistic or pessimistic outlook, depending on how they interpret the data. The index has shown a price loss of -35.45% this year. Over the last six months, there has been a stronger performance of -42.03%. The price of KYMR leaped by -23.32% during the last 30 days period. For the last 5-days stocks have improved 15.94%.

Most Popular